Notably, the Radvanyi Breast dataset showed that the golgin-97 mRNA levels in invasive ductal breast carcinoma were lower (2.293-fold change with a p-value = 0.011) than those in ductal breast carcinoma in situ (Fig. 1c). This evidence concerns the gene GOLGA1 and ductal breast carcinoma in situ.